AMRYT PHARMA PLC's ticker is AMYT and the CUSIP is 03217L106. A total of 62 filers reported holding AMRYT PHARMA PLC in Q4 2021. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $129,138,967 | +99.7% | 8,857,268 | 0.0% | 46.27% | +70.3% |
| Q4 2022 | $64,658,056 | +5.5% | 8,857,268 | 0.0% | 27.18% | +18.4% |
| Q3 2022 | $61,292,000 | -1.0% | 8,857,268 | 0.0% | 22.96% | -11.8% |
| Q2 2022 | $61,912,000 | -15.5% | 8,857,268 | 0.0% | 26.04% | 0.0% |
| Q1 2022 | $73,250,000 | -23.4% | 8,857,268 | 0.0% | 26.04% | -23.6% |
| Q4 2021 | $95,658,000 | +75.7% | 8,857,268 | +96.0% | 34.10% | -1.2% |
| Q3 2021 | $54,443,000 | -0.7% | 4,520,000 | 0.0% | 34.53% | +51.1% |
| Q2 2021 | $54,828,000 | -12.9% | 4,520,000 | 0.0% | 22.86% | -28.2% |
| Q1 2021 | $62,964,000 | -1.6% | 4,520,000 | 0.0% | 31.84% | +3.2% |
| Q4 2020 | $64,003,000 | – | 4,520,000 | – | 30.84% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 8,857,268 | $64,658,056 | 27.18% |
| Stonepine Capital Management, LLC | 6,333,239 | $46,232,645 | 19.45% |
| MPM ASSET MANAGEMENT LLC | 2,668,843 | $19,482,554 | 8.15% |
| Aquilo Capital Management, LLC | 2,098,993 | $15,322,649 | 5.76% |
| New Leaf Venture Partners, L.L.C. | 449,737 | $3,283,080 | 2.38% |
| Global Frontier Investments LLC | 505,000 | $3,687 | 1.62% |
| Telemetry Investments, L.L.C. | 130,262 | $951 | 1.50% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 6,333,552 | $46,235 | 1.27% |
| Rubric Capital Management LP | 3,600,000 | $26,280,000 | 1.15% |
| Clearline Capital LP | 631,942 | $4,613,176 | 0.82% |